<DOC>
	<DOCNO>NCT00599001</DOCNO>
	<brief_summary>The main purpose study assess safety , tolerability , biological activity SD-101 compare placebo healthy male volunteer .</brief_summary>
	<brief_title>Safety , Pharmacokinetics , Pharmacodynamics SD-101 Healthy Normal Males</brief_title>
	<detailed_description>This Phase 1 , randomize , single-blind , placebo-controlled study five escalate dose level SD-101 healthy male volunteer . The objective study assess safety , tolerability , pharmacokinetic profile , pharmacodynamics SD-101 . Approximately 40 subject participate . Once subject consent , screen , assign one dose level SD-101 , subject receive single subcutaneous injection either SD-101 placebo ( PBS ) ratio 6:2 . Safety tolerability evaluate occurrence adverse event , blood urine laboratory test , physical examination finding , vital sign , electrocardiogram finding . Pharmacodynamics evaluate level blood biomarkers serum cytokine , flow cytometric cell count . Pharmacokinetics evaluate level study drug serum .</detailed_description>
	<criteria>Signed , write , informed consent must obtain subject studyspecific procedure perform . Subject must male 18 year age old . Subject must willing submit urine drug screen agree abstain alcohol , caffeine , tobacco require stay Phase I Unit . Subject must willing abide rule Phase 1 Unit . Subjects whose sexual partner childbearing potential must agree use effective method birth control ( i.e. , chemical contraceptive , barrier plus spermicide , intrauterine device ) treatment phase 14 day post treatment . Must negative Hepatitis B C human immunodeficiency virus ( HIV ) . Females . Clinically significant active , acute , chronic illness . History coagulation bleed disorder . Clinically significant chronic recent ( within 21 day dose ) acute gastrointestinal disorder nausea , vomit diarrhea major symptom . Received vaccine within 3 week study entry plan vaccinate within 6 week study injection . History significant cardiovascular cerebrovascular disease . History evaluation autoimmune disease include systemic lupus erythematosus ( SLE ) , rheumatoid arthritis ( RA ) , scleroderma thyroiditis . Significant psychiatric illness could potentially interfere assessment study . Subjects prior surgery major infection within 6 month dose . History medication within 7 day dose , except vitamin and/or mineral . History Gilbert 's disease .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>research subject</keyword>
	<keyword>Immunostimulatory sequence ( ISS )</keyword>
	<keyword>phase 1</keyword>
</DOC>